March 2012
Volume 53, Issue 14
ARVO Annual Meeting Abstract  |   March 2012
Localisation Of The P2X7 Receptor In The Human Retina Using A Novel mRNA Profiling Technique
Author Affiliations & Notes
  • Julie Sanderson
    School of Pharmacy,
    University of East Anglia, Norwich, United Kingdom
  • Ning Ma
    School of Pharmacy,
    University of East Anglia, Norwich, United Kingdom
  • Jeremy D. Rhodes
    School of Biology,
    University of East Anglia, Norwich, United Kingdom
  • David C. Broadway
    Department of Ohthalmology, Norfolk and Norwich University Hospital, Norwich, United Kingdom
  • Footnotes
    Commercial Relationships  Julie Sanderson, None; Ning Ma, None; Jeremy D. Rhodes, None; David C. Broadway, None
  • Footnotes
    Support  The Humane Research Trust, The Norwich Glaucoma Research Fund.
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 2244. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Julie Sanderson, Ning Ma, Jeremy D. Rhodes, David C. Broadway; Localisation Of The P2X7 Receptor In The Human Retina Using A Novel mRNA Profiling Technique. Invest. Ophthalmol. Vis. Sci. 2012;53(14):2244.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : We have previously shown that activation of P2X7 receptors in the human retina causes loss of retinal ganglion cells (RGCs). However, currently the localization of the P2X7 receptor in the retina is not clear. The purpose of these experiments was to determine the localisation of the P2X7 receptor in the human retina using a novel mRNA profiling technique.

Methods: : Human retina was obtained from the East Anglian Eye Bank within 24 hours post mortem. The macula region of the retina was dissected, mounted and cryosectioned (20µm sections) in the plane of the retinal nuclear layers. RNA was extracted and QRT-PCR conducted for retinal markers (RCVRN; photoreceptors, CALB; horizontal cells, CHAT; amacrine cells and THY-1; RGCs) and P2X7 (P2X7R) mRNA (n=6). Immunohistochemistry was carried out on transverse sections for P2X7 receptor using an antibody raised to the extracellular domain.

Results: : P2X7 receptor mRNA was found to be expressed in the human retina. There was no significant difference between expression in the macula and expression in peripheral retina (n=4). Expression was low in the outer retina with no coincidence with the photoreceptor marker recoverin (RCVRN). The initial peak of P2X7 expression corresponded with calbindin (CALB) expression and then remained elevated, including in the retinal ganglion cell layer. Immunohistochemistry showed labelling in the outer plexiform layer with less intense labelling evident in the inner plexiform layer.

Conclusions: : The P2X7 receptor was located in the outer and inner plexiform layers of the human retina. There was no evidence for expression in the photoreceptors, but P2X7R mRNA expression was coincident with the horizontal cell marker CALB. In the inner retina, P2X7R expression was coincident with both amacrine and RGC markers. This suggests that RGCs do express the P2X7 receptor and that RGC death occurring as a result of P2X7 stimulation could be mediated by direct mechanisms although indirect mechanisms may also play a role.

Keywords: neuroprotection • ganglion cells • retinal culture 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.